Julie M. Gastier-Foster, PhD

Nationwide Children's Hospital Medical Professional

Contact Information

Biography

Julie Gastier-Foster, PhD, FACMG, is the Senior Director of the Institute for Genomic Medicine Clinical Laboratory and Vice Chair of Laboratory Genetics in the Department of Pathology and Laboratory Medicine. She is a Professor (Clinical) in the Departments of Pathology and Pediatrics at the OSU College of Medicine.

Dr. Gastier-Foster received her PhD from Harvard Medical School, and completed her medical genetics training at Stanford University. She is board-certified in Clinical Cytogenetics and Clinical Molecular Genetics and has nearly 20 years’ experience overseeing CAP/CLIA-certified laboratories. Dr. Gastier-Foster has significant translational research funding to support the integration of genetic/genomic testing into clinical trials and promote biobanking and tumor processing. She is responsible for the Children's Oncology Group (COG) Molecular Reference Laboratories and the COG and SWOG Leukemia Banks.

She serves as the Principal Investigator for the COG reference laboratories, providing real time clinical testing for risk-based stratification of patients. Dr. Gastier-Foster has utilized her biorepository and tumor processing expertise as the Principal Investigator of the National Cancer Institute (NCI) Center for Cancer Genomics Biospecimen Core Resource (BCR) since 2009. The BCR is responsible for tumor pathology review and processing for large scale genomics projects such as The Cancer Genome Atlas (TCGA).

See Julie M. Gastier-Foster’s Curriculum Vitae (CV)

Academic and Clinical Areas
Awards, Honors & Organizations
  • Graduate Student Award (Catherine Cottrell, PhD student), Columbus Children’s Research Institute, 2004
  • Postdoctoral Fellow Award (Robin LeGallo, MD), Columbus Children's Research Institute, 2004
  • Gordon L. Vawter Pathologist-in-Training Award (Malti Pathak, Medical Student), Society for Pediatric Pathology, 2003
  • Member, American College of Medical Genetics and Genomics
  • Member, American Society of Hematology
  • Member, American Society of Human Genetics
  • Member, Association for Molecular Pathology
  • Member, Association of Genetic Technologists
  • Member, Cancer Genomics Consortium
  • Member, Children’s Oncology Group
  • Member, International Cancer Genomics Consortium
  • Member, Phi Kappa Phi Honor Society
  • Member, SWOG (formerly Southwest Oncology Group)
Education

Date of Appointment at Nationwide Children’s Hospital: 09/13/1999

Fellowship STANFORD UNIVERSITY SCHOOL OF MEDICINE Date Completed: 09/03/1999
Graduate School HARVARD MEDICAL SCHOOL Date Completed: 06/01/1996
Professional Experience

2016 - Present Nationwide Children's Hospital, Institute for Genomic Medicine, Senior Director

2012 - Present Nationwide Children's Hospital, Vice Chair, Path/Lab Med, Laboratory Genetics

2009 - Present Integrated Biomedical Science Graduate Program, Ohio State University School of Medicine, Associate Professor

2009 - Present Children’s Oncology Group Wilms Tumor Reference Laboratory, The Research Institute at Nationwide Children’s, Scientific Director

2009 - Present Clinical Department of Pediatrics, Ohio State University School of Medicine, Associate Professor

2009 - Present Clinical Department of Pathology, Ohio State University School of Medicine, Associate Professor

2007 - Present Biopathology Center The Research Institute at Nationwide Children’s Hospital, Assistant Medical Director

2006 - Present Children’s Oncology Group Neuroblastoma Reference Laboratory, The Research Institute at Nationwide Children’s Hospital, Scientific Director

2005 - Present Clinical Molecular Genetics, Clinical Cytogenetics Fellowship Program, Nationwide Children’s Hospital, Laboratory Training Director

2002 - Present Children’s Oncology Group Acute Lymphoblastic Leukemia Molecular Reference Laboratory, Scientific Director

2006 - 2009 Clinical Department of Pediatrics, Ohio State University School of Medicine, Assistant Professor

2002 - 2009 Integrated Biomedical Science Graduate Program, Ohio State University School of Medicine, Assistant Professor of Clinical Pediatrics

1999 - 2009 Clinical Department of Pathology, Ohio State University School of Medicine, Assistant Professor

1999 - 2002 Cytogenetics Laboratory, Nationwide Children’s Hospital, Assistant Director

1996 - 1999 Howard Hughes Medical Institute, Stanford University School of Medicine, Research Associate/Laboratory Manager

Research Funding
CHOP/NIH/NCI

ARST1431 BIQSFP, Principal Investigator

Funding Period: 03/01/16-04/30/20

Children’s Oncology Group Foundation

COG Neuroblastoma Reference Laboratory, Principal Investigator

Funding Period: 03/01/17-02/28/18

Leidos Biomedical Research Inc./NIH/NCI

Pediatric NCI-MATCH APEC1621, Principal Investigator

Funding Period: 02/01/17-09/25/21

Leidos Biomedical Research Inc./NIH

Ovarian Met Pilot Project (OMPS), Principal Investigator

Funding Period: 01/17/17-07/16/17

Leidos Biomedical Research Inc./NIH/NCI

Genetic Epidemiology of Kidney Cancer Etiology (GEPIKID), Principal Investigator

Funding Period: 02/13/17-07/31/17

Leidos Biomedical Research Inc./NIH/NCI

Hong Kong Breast Project (HKB), Principal Investigator

Funding Period: 01/10/17-08/31/17

Leidos Biomedical Research Inc./NIH/NCI

Prostate, Lung, Colon, and Ovary Cancer Screening Trial, Principal Investigator

Funding Period: 01/25/17-08/31/17

Leukemia and Lymphoma Society

A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial), Principal Investigator

10/01/16-09/30/19

Childrens Hospital of Philadelphia (CHOP)/Incyte Corporation

AALL1521 Lab Work, Principal Investigator

Funding Period: 09/06/16-03/5/20

Leidos Biomedical Research/NIH

DCEG Multiple Primaries Project, Principal Investigator

Funding Period: 10/05/16-08/31/17

Leidos Biomedical Research Inc./NIH/NCI

Pediatric NCI-MATCH APEC1621 - Informatics, Principal Investigator

Funding Period: 07/01/16-06/30/17

Children’s Oncology Group Foundation/St. Baldrick’s Foundation

Project Every Child, Principal Investigator

Funding Period: 07/01/16-06/30/18

Children’s Oncology Group Foundation

Centralized FOXO1 FISH Testing, Co-Principal Investigator

Funding Period: 06/01/16-05/31/18

Alex’s Lemonade Stand

PPTC PDX, Principal Investigator

Funding Period: 05/01/16-10/31/17

Johns Hopkins University/Breast Cancer Research Foundation

Aurora US Project, Principal Investigator

Funding Period: 02/01/16-06/30/17

Leidos Biomedical Research Inc./NIH/NCI

Chernobyl Genomics Study (CGS), Principal Investigator

Funding Period: 12/14/15-07/31/17

OSU College of Medicine/NIH

Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry, Co-Principal Investigator

Funding Period: 09/15/15-04/30/20

St. Jude Children’s Research Hospital/NIH

Center for Precision Medicine in Leukemia (P50), Co-Investigator

Funding Period: 07/01/15-06/30/20

NIH/NCI

COG Biospecimen Bank, Principal Investigator (multiple PI)

Funding Period: 04/01/15-03/31/20

NIH/NCI

SWOG Biospecimen Bank, Principal Investigator (multiple PI)

Funding Period: 04/01/15-03/31/20

NIH/NCI

NRG Oncology Biospecimen Bank, Co-Investigator

Funding Period: 04/01/15-03/31/20

Leidos Biomedical Research Inc./NIH/NCI

Cancer Driver Discovery Program (CDDP), Principal Investigator

Funding Period: 03/01/15-08/31/17

Leidos Biomedical Research Inc./NIH/NCI

Center for Cancer Genomics Biospecimen Core Resource (CCG/BCR), Principal Investigator

Funding Period: 03/01/15-08/31/17

Leidos Biomedical Research Inc./NIH/NCI

Alchemist, Principal Investigator

Funding Period: 09/15/14-08/31/17

Leidos Biomedical Research Inc./NIH/NCI

Exceptional Responders Initiative, Principal Investigator

Funding Period: 08/04/14-08/31/17

Children’s Hospital of Philadelphia/NIH/NCI

COG NCTN Solid Malignancy Integrated Translational Science Ctr, Other

Funding Period: 03/01/14-02/28/19

Children’s Oncology Group/NIH/NCI

ANBL1232 Integral Marker Testing, Other

Funding Period: 03/01/14-02/28/19

New York University School of Medicine/Leukemia & Lymphoma Society

Developing Novel Therapies for Pediatric and Young Adult ALL, Co-Investigator

Funding Period: 10/01/13-09/30/18

Children’s Hospital of Philadelphia/St. Baldrick’s Foundation

Testing Targeted Therapy in Philadelphia Chromosome-like (Ph-like) ALL, Co-Investigator

Funding Period: 07/01/13-06/30/18

The Hope Foundation

SWOG CD138, Principal Investigator

Funding Period: 10/01/12-09/30/17

Leidos Biomedical Research Inc./NIH/NCI

Burkitt Lymphoma Project, Principal Investigator

Funding Period: 09/24/12-09/23/17

Leidos Biomedical Research Inc./NIH/NCI

Collection of Clinical Data for the OCG Projects (HIV+ Tumor Project), Principal Investigator

Funding Period: 06/20/12-06/19/17

Bristol-Myers Squibb Pharmaceutical Research Institute

Laboratory Services Agreement: Bristol-Myers Squibb, Principal Investigator

Funding Period: 11/16/11-11/15/21

NIH/National Cancer Institute

Pediatric CHTN: New Scope/Technology Aids Cancer Research, Co-Investigator

Funding Period: 04/01/14-03/31/20

Contact Information
Institute for Genomic Medicine